Diabetes technology

Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Cardiovascular Intensive Care Unit

J Diabetes Sci TechnolPublished Pilot feasibility and accuracy study

Authors' conclusion

This pilot study demonstrates the feasibility, accuracy, and nursing convenience of adopting CGM via a hybrid approach for insulin titration in postoperative settings. These findings provide robust rationale for larger confirmatory studies to evaluate the benefit of CGM in postoperative care to improve workflow, enhance health outcomes, and cost-effectiveness.

Study context

Population
Postsurgical patients with hyperglycemia receiving continuous IV insulin infusion in the cardiovascular ICU; mean age 64, 32% female, 32% with diabetes864 paired values analysed
Participants
59 patients
Outcome
CGM accuracy vs POC-BG
Methodological detailssingle-group, hybrid approach with periodic point-of-care blood glucose (POC-BG) validation
  • Single-group
  • Hybrid approach with periodic POC-BG validation

Performance

As reported in the abstract

Test or modelMean absolute relative differenceMedian absolute relative differencePaired values in Clarke Error Grid Zones A and B
Continuous glucose monitoring (CGM)13.2%9.8%99.7%

Continuous glucose monitoring (CGM)

Mean absolute relative difference13.2%
Median absolute relative difference9.8%
Paired values in Clarke Error Grid Zones A and B99.7%

Further findings

Nursing acceptance

Nurses reporting CGM very or quite convenient
n = 28; 93%
Nurses favouring CGM over POC-BG testing
n = 28; 93%

Patient satisfaction

Patients reporting care process using CGM as good or very good
n = 42; 93%

Original publication

Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Cardiovascular Intensive Care Unit. J Diabetes Sci Technol. Published 2 April 2024. doi:10.1177/19322968241241005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.